Status:

TERMINATED

A Pilot Study to Characterise Saliva and Sputum FTIR Spectral Profiles in Patients with COPD During Exacerbations and When Stable

Lead Sponsor:

Portsmouth Hospitals NHS Trust

Conditions:

Chronic Obstructive Pulmonary Disease

Eligibility:

All Genders

40+ years

Brief Summary

This study will characterise saliva and sputum FTIR spectral profiles in patients with COPD, during exacerbations and stable disease.

Detailed Description

Chronic Obstructive Pulmonary Disease (COPD) is a common and treatable condition that is characterised by predominately irreversible and progressive airflow limitation. COPD is a leading cause of morb...

Eligibility Criteria

Inclusion

  • Participants with a confirmed diagnosis of an exacerbation of COPD (aged ≥40 years), n=40 (20 participants recruited in phase 1 and 20 participants recruited in phase 2) who are able to spontaneously expectorates sputum during exacerbations and on at least 3 out of 7 days when well.
  • Able to provide written informed consent

Exclusion

  • Participants with other significant respiratory disease that, in the opinion of the clinical investigator, is the major cause of their respiratory symptoms (e.g. pulmonary tuberculosis, allergic bronchopulmonary aspergillosis, pulmonary fibrosis).
  • Participants with COPD whose deterioration in respiratory symptoms is not thought to be due to an exacerbation of their COPD (e.g. pneumonia\*, pneumothorax, pulmonary embolus).
  • A member of the research study medical team will review the participant's chest X-Ray (CXR) to exclude any pneumonia, defined by consolidation on CXR before they are recruited onto the study if a CXR has been taken. In participants who have not had a CXR, exclusion of pneumonia will be based on clinical assessment.

Key Trial Info

Start Date :

September 18 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

October 31 2023

Estimated Enrollment :

27 Patients enrolled

Trial Details

Trial ID

NCT04524819

Start Date

September 18 2019

End Date

October 31 2023

Last Update

November 8 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Portsmouth Hospitals NHS Trust, Queen Alexandra Hospital

Portsmouth, Hampshire, United Kingdom, PO6 3LY

A Pilot Study to Characterise Saliva and Sputum FTIR Spectral Profiles in Patients with COPD During Exacerbations and When Stable | DecenTrialz